Medsafe (New Zealand Medicines and Medical Devices Safety Authority, Ministry of Health)
Is Setmelanotide legal in New Zealand?
Not approvedNo setmelanotide product is approved by Medsafe or listed with a data sheet
Not approved as a medicine here.
Medsafe's index of data sheets for consented medicines, revised 29 September 2026, lists no setmelanotide product (no Imcivree entry), and the Pharmaceutical Schedule has no funded setmelanotide. The Medsafe classification database has a group entry for melanocyte-stimulating compounds as prescription medicines, which is not an approval. A prescriber could only obtain it for a named patient under the narrow unapproved-medicine exemptions. Medsafe's Product/Application Search showed no setmelanotide product or application on 29 September 2026.
Last verified 2026-09-29 · how we verify
Setmelanotide elsewhere
Sources (5)
- 01Data sheets index (medicines with consent to be distributed in New Zealand)Medsafe (New Zealand Medicines and Medical Devices Safety Authority) · 2026-09-29 · accessed 2026-09-29
- 02Pharmaceutical Schedule, October 2026 (Volume 33)Pharmac (Pharmaceutical Management Agency) · 2026-10 · accessed 2026-09-29
- 03Medicines Classification Database (Schedule 1, Medicines Regulations 1984)Medsafe (New Zealand Medicines and Medical Devices Safety Authority) · 2026-09-25 · accessed 2026-09-29
- 04Use of Unapproved Medicines and Use of approved Medicines for an unapproved purposeMedsafe (New Zealand Medicines and Medical Devices Safety Authority) · 2025-12-12 · accessed 2026-09-29
- 05Product/Application Search (product and application records searched by ingredient on 29 September 2026)Medsafe (New Zealand Medicines and Medical Devices Safety Authority) · 2026-07-07 · accessed 2026-09-29